Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,016.00    0.00 (0.00%)
Bid:
1,022.00
Ask:
1,026.00
Spread: 4.00 (0.391%)
Market Cap: £145.79b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Prospectus Exemption

23 Apr 2026 07:40

RNS Number : 6416B
Banco Santander S.A.
23 April 2026
 

 

 

 

Banco Santander, S.A. ("Banco Santander"), in accordance with the provisions of securities market legislation, hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

In connection with the issuance of up to 334,809,216 new ordinary shares of Banco Santander in the context of its acquisition of Webster Financial Corporation, it is hereby noted that Banco Santander is not required to publish, and will not publish, a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017, on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). Banco Santander has elected to rely on the exemptions set forth in Article 1(4)(da) and Article 1(5)(a) of the Prospectus Regulation.

 

To that end, Banco Santander has today published on its corporate website (www.santander.com) an exemption document (the "Exemption Document"), in accordance with the requirements of Annex IX of the Prospectus Regulation. The Exemption Document has been filed with the National Securities Market Commission (Comisión Nacional del Mercado de Valores, "CNMV") and made available to the public in accordance with Article 21(2) of the Prospectus Regulation. The Exemption Document is available at https://www.santander.com/content/dam/santander-com/es/documentos/aumento-de-capital-para-la-adquisicion-de-webster/exemption-document.pdf

 

The Exemption Document does not constitute a prospectus within the meaning of the Prospectus Regulation and is not subject to review and approval under Article 20 thereof. Accordingly, it has not been reviewed or approved by the CNMV.

 

 

Boadilla del Monte (Madrid), 23 April 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCIJMFTMTJTMIF
Date   Source Headline
3rd Oct 20252:58 pmRNSMoody's has upgraded Santanders rating
2nd Oct 20255:15 pmRNSDirector/PDMR Shareholding
2nd Oct 202511:07 amRNSBuyback programme: Transactions 25Sept-1Oct
30th Sep 20252:23 pmRNSDividend approval
30th Sep 202511:56 amRNSTotal Voting Rights
25th Sep 202511:12 amRNSBuyback programme: transactions 18-24Sept
18th Sep 202511:04 amRNSBuyback programme: transactions 11-17Sept
11th Sep 20254:54 pmRNSDirector/PDMR Shareholding
11th Sep 202511:07 amRNSBuyback programme: transactions 4-10Sept
4th Sep 202511:04 amRNSBuyback programme: transactions 28Aug-3Sept
29th Aug 20254:35 pmRNSTotal Voting Rights
29th Aug 202511:34 amRNSModification of internationalization covered bonds
28th Aug 202511:04 amRNSBuyback programme: transactions 21-27Aug
21st Aug 202511:04 amRNSBuyback programme: transactions 14-20Aug
14th Aug 202511:08 amRNSBuyback programme: transactions 7-13Aug
11th Aug 202511:09 amRNSDirector/PDMR Shareholding
7th Aug 202511:09 amRNSBuyback programme: transactions 31Jul - 6Aug
1st Aug 20255:48 pmRNSStress test Results
31st Jul 20254:57 pmRNSTotal Voting Rights
31st Jul 202512:07 pmRNSHalf-year Report
30th Jul 20257:00 amRNS1st Half 25 results report & earnings presentation
30th Jul 20257:00 amRNSFirst Half 2025 Results - Press release
30th Jul 20257:00 amRNSCommencement of a program to repurchase own shares
23rd Jul 202511:11 amRNSNotice of First Half 2025 Results
2nd Jul 20257:00 amRNSPresentation to analysts about transaction on TSB
1st Jul 20256:20 pmRNSSantander to acquire TSB. Analysts meeting notice
1st Jul 20252:55 pmRNSInvitation to buy outstanding preferred securities
30th Jun 202511:55 amRNSTotal Voting Rights
27th Jun 20254:49 pmRNSDirector/PDMR Shareholding
27th Jun 20254:47 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSInvitation to buy outstanding preferred securities
24th Jun 20257:48 amRNSInvitation to buy outstanding preferred securities
20th Jun 20255:16 pmRNSDirector/PDMR Shareholding
10th Jun 20253:54 pmRNSFurther re Capital reduction
10th Jun 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:38 pmRNSTotal Voting Rights
3rd Jun 202510:00 amRNSCapital reduction following completion of program
2nd Jun 202512:08 pmRNSTotal Voting Rights
29th May 202511:12 amRNSBuyback programme: transactions 22-28May
22nd May 202511:05 amRNSBuyback programme: transactions 14-21May
21st May 202512:41 pmRNSDirector/PDMR Shareholding
20th May 202512:57 pmRNSDirector/PDMR Shareholding
14th May 20255:36 pmRNSDirector/PDMR Shareholding
14th May 20253:33 pmRNSBuyback programme: transactions 7-13May
13th May 20254:11 pmRNSDirector/PDMR Shareholding
9th May 20251:17 pmRNSDirector/PDMR Shareholding
9th May 20251:10 pmRNSDirector/PDMR Shareholding
7th May 20255:26 pmRNSDirector/PDMR Shareholding
7th May 20254:58 pmRNSSantander informs of the MREL determined by SRB
7th May 202511:09 amRNSBuyback programme: transactions 29Apr-6May

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.